Dupont data supports earlier findings.


Research data from Dupont's 006 study was presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The study compares the non-nucleoside Sustiva (efavirenz) combined with Retrovir (ziduvodine, AZT) and Epivir (lamivudine, 3TC) against the protease inhibitor Crixivan with Retrovir and Epivir. Data was reviewed to… (More)


Cite this paper

@article{Slovick1999DupontDS, title={Dupont data supports earlier findings.}, author={J Slovick}, journal={Positive living}, year={1999}, volume={8 10}, pages={45} }